Richard Lee

Dr. Richard Lee comes to the Kira team after serving as Head of Hematology at Alexion Pharmaceuticals, a global company specializing in rare diseases. He has served in clinical and medical affairs leadership roles at pharmaceutical and biotechnology companies including Bayer, Roche, Genentech, Millennium/Takeda, and Bristol-Myers-Squibb, gaining significant experience developing products across a large spectrum of small molecules, proteasome inhibitors, and large biologics. He has been crucial in the development and launch of first-to-market medicines throughout his career.

He completed his MD from Indiana University School of Medicine, MBA from George Washington University and his Bachelor of Science degree in Chemistry from the University of Arizona.